Prolactin action and signalling in the human endometrium

Reproductive Medicine Review

Volumn 10, Issue 2, 2002, Pages 117-132

  Jabbour, H N ^a,b   Gubbay, O ^a   Critchley, H O D ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b MRC Reproductive Biology Unit   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ISOPROTEIN; JANUS KINASE; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL KINASE; PROLACTIN; PROLACTIN RECEPTOR; STAT PROTEIN; STAT1 PROTEIN; STAT2 PROTEIN; STAT3 PROTEIN; STAT4 PROTEIN; STAT5 PROTEIN; STAT6 PROTEIN;

ANGIOGENESIS; DIMERIZATION; ENDOMETRIUM; FEMALE; GENE EXPRESSION REGULATION; HORMONAL REGULATION; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROLACTIN RELEASE; RECEPTOR BINDING; REVIEW; SIGNAL TRANSDUCTION;

EID: 0036630069     PISSN: 09622799     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0962279902000236     Document Type: Review

References (87)

1. Ben-Jonathan N, Mershon JL, Allen DL, Steinmetz RW. Extrapituitary prolactin: Distribution, regulation, functions and clinical aspects. Endocr Rev 1996; 17: 639-69.
2. Yu-Lee L. Molecular actions of prolactin in the immune system. Proc Soc Exp Biol Med 1997; 215: 35-52.
3. Bole-Feysot C, Goffin V, Edery M, Binart N, Kelly PA. Prolactin (PRL] and its receptor: Actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice. Endocr Rev 1998; 19: 225-68.
4. Niall HD, Hogan ML, Sauer R, Rosenblum IY, Greenwood FC. Sequences of pituitary and placental lactogenic and growth hormones: Evolution from a primordial peptide by gene reduplication. Proc NatlAcad Sci USA 1971; 68: 866-70.
5. Cunningham BC, Henner DJ, Wells JA. Engineering human prolactin to bind to the human growth hormone receptor. Science 1990; 247: 1461-5.
6. Wu WX, Brooks J, Glasier AF, McNeilly AS. The relationship between decidualisation and prolactin mRNA and production at different stages of human pregnancy. J Mol Endocrinol 1995; 14: 255-61.
7. Tomita K, McCoshen JA, Fernandez CS, Tyson JE. Immunologic and biologic characteristics of human decidual prolactin. Am J Obstet Gynecol 1982; 142: 420-6.
8. Takahashi H, Nabeshima Y, Ogata K, Takeuchi S. Molecular cloning and nucleotide sequence of DNA complementary to human decidual prolactin mRNA. J Biochem 1984; 95: 1491-9.
9. Golander A, Barrett J, Hurley T, Barry S, Handwerger S. Failure of bromocriptine, dopamine, and thyrotropin-releasing hormone to affect prolactin secretion by human decidual tissue in vitro. J Clin Endocrinol Metabol 1979; 49: 787-9.
10. Huang JR, Tseng L, Bischof P, Janne OA. Regulation of prolactin production by progestin, estrogen, and relaxin in human endometrial stromal cells. Endocrinology 1987; 121: 2011-17.
11. Gellersen B, Kempf R, Telgmann R, DiMattia GE. Nonpituitary human prolactin gene transcription is independent of Pit-1 and differentially controlled in lymphocytes and in endometrial stroma. Mol Endocrinol 1994; 8: 356-73.
12. Maslar IA, Ansbacher R. Effects of progesterone on decidual prolactin production by organ cultures of human endometrium. Endocrinology 1986; 118: 2102-8.
13. Reis FM, Maia AL, Ribeiro MF, Spritzer PM. Progestin modulation of c-fos and prolactin gene expression in the human endometrium. Fertil Steril 1999; 71: 1125-32.
14. Wang JD, Zhu JB, Shi WL, Zhu PD. Immunocytochemical colocalization of progesterone receptor and prolactin in individual stromal cells of human decidua. J Clin Endocrinol Metabol 1994; 79: 293-7.
15. Gellersen B, DiMattia GE, Friesen HG, Bohnet HG. Prolactin (PRL) mRNA from human decidua differs from pituitary PRL mRNA but resembles the IM-9-P3 lymphoblast PRL transcript. Mol Cell Endocrinol 1989; 64: 127-30.
16. Brosens JJ, Hayashi N, White JO. Progesterone receptor regulates decidual prolactin expression in differentiating human endometrial stromal cells. Endocrinology 1999; 140: 4809-20.
17. Telgmann R, Maronde E, Tasken K, Gellersen B. Activated protein kinase A is required for differentiation-dependent transcription of the decidual prolactin gene in human endometrial stromal cells. Endocrinology 1997; 138: 929-37.
18. Pohnke Y, Kempf R, Gellersen B. CCAAT/enhancer-binding proteins are mediators in the protein kinase A- dependent activation of the decidual prolactin promoter. J Biol Chem 1999; 274: 24808-18.
19. Kelly PA, Djiane J, Postel-Vinay MC, Edery M. The prolactin/growth hormone receptor family. Endocr Rev 1991; 12: 235-51.
20. Bazan JF. A novel family of growth factor receptors: A common binding domain in the growth hormone, prolactin, erythropoietin and IL-6 receptors, and the p75 IL-2 receptor beta-chain. Biochem Biophys Res Commun 1989; 164: 788-95.
21. Bazan JF. Structural design and molecular evolution of a cytokine receptor superfamily. Proc Natl Acad Sci USA 1990; 87: 6934-8.
22. Goffin V, Kelly PA. Prolactin and growth hormone receptors. Clin Endocrinol 1996; 45: 247-55.
23. Goffin V, Binart N, Touraine P, Kelly PA. PROLACTIN: The new biology of an old hormone. Annu Rev Physiol 2002; 64: 47-67.
24. Hu ZZ, Zhuang L, Meng J, Leondires M, Dufau ML. The human prolactin receptor gene structure and alternative promoter utilization: The generic promoter hPIII and a novel human promoter hP(N). J Clin Endocrinol Metabol 1999; 84: 1153-6.
25. Hu ZZ, Meng J, Dufau ML. Isolation and characterization of two novel forms of the human prolactin receptor generated by alternative splicing of a newly identified exon 11. J Biol Chem 2001; 276: 41086-94.
26. Kline JB, Roehrs H, Clevenger CV. Functional characterization of the intermediate isoform of the human prolactin receptor. J Biol Chem 1999; 274: 35461-8.
27. Jones RL, Critchley HOD, Brooks J, Jabbour HN, McNeilly AS. Localization and temporal pattern of expression of prolactin receptor in human endometrium. J Clin Endocrinol Metabol 1998; 83: 258-62.
28. Jabbour HN, Critchley HO, Boddy SC. Expression of functional prolactin receptors in nonpregnant human endometrium: Janus kinase-2, signal transducer and activator of transcription-1 (STAT1), and STAT5 proteins are phosphorylated after stimulation with prolactin. J Clin Endocrinol Metabol 1998; 83: 2545-53.
29. Frasor J, Gaspar CA, Donnelly KM, Gibori G, Fazleabas AT. Expression of prolactin and its receptor in the baboon uterus during the menstrual cycle and pregnancy. J Clin Endocrinol Metabol 1999; 84: 3344-50.
30. Dalrymple A, Jabbour HN. Localization and signaling of the prolactin receptor in the uterus of the common marmoset monkey. J Clin Endocrinol Metabol 2000; 85: 1711-18.
31. Gubbay O, Critchley HOD, Bowen JM, King A, Jabbour HN. Prolactin induces ERK phosphorylation in epithelial and CD56+ natural killer cells of the human endometrium. J Clin Endocrinol Metabol 2002 (in press).
32. Maaskant RA, Bogic LV, Gilger S, Kelly PA, Bryant-Greenwood GD. The human prolactin receptor in the fetal membranes, decidua, and placenta. J Clin Endocrinol Metabol 1996; 81: 396-405.
33. Jabbour HN, Critchley HO. Potential roles of decidual prolactin in early pregnancy. Reproduction 2001; 121: 197-205.
34. Kinet S, Goffin V, Mainfroid V, Martial JA. Characterization of lactogen receptor-binding site 1 of human prolactin. J Biol Chem 1996; 271: 14353-60.
35. Heim MH. The JaK-STAT pathway: Cytokine signalling from the receptor to the nucleus. J Recept Signal Transduct Res 1999; 19: 75-120.
36. Ihle JN, Kerr IM. JaKs and STATs in signaling by the cytokine receptor superfamily. Trends Genet 1995; 11: 69-74.
37. Groner B, Gouilleux F. Prolactin-mediated gene activation in mammary epithelial cells. Curr Opin Genet Dev 1995; 5: 587-94.
38. Burdon TG, Demmer J, Clarke JA, Watson CJ. The mammary factor MPBF is a prolactin-induced transcription regulator which binds to STAT factor recognition sites. Eur Biochem Soc 1994; 350: 177-82.
39. Russell DL, Norman RL, Dajee M, Liu X, Hennighausen L, Richards JS. Prolactin-induced activation and binding of STAT proteins to the IL-GRE of the α2-macroglobulin (αApromoter: Relation to the expression of α2M in the rat ovary. Biol Reprod 1996; 55: 1029-38.
40. Feltus FA, Groner B, Melner MH. STAT5-mediated regulation of the human type II 3beta-hydroxysteroid dehydrogenase/delta5-delta4 isomerase gene: Activation by prolactin. Mol Endocrinol 1999; 13: 1084-93.
41. Jabbour HN, Critchley HO, Yu-Lee LY, Boddy SC. Localization of interferon regulatory factor-1 (IRF-1) in nonpregnant human endometrium: Expression of IRF-1 is up-regulated by prolactin during the secretory phase of the menstrual cycle. J Clin Endocrinol Metabol 1999; 84: 4260-5.
42. Dogusan Z, Hooghe R, Verdood P, Hooghe-Peters EL. Cytokine-like effects of prolactin in human mononuclear and polymorphonuclear leukocytes. J Neuroimmunol 2001; 120: 58-66.
43. Rao YP, Buckley DJ, Buckley AR. Rapid activation of mitogen-activated protein kinase and p21ras by prolactin and interleukin 2 in rat Nb2 node lymphoma cells. Cell Growth Differ 1995; 6: 1235-44.
44. Das R, Vonderhaar BK. Involvement of SHC, GRB2, SOS and RAS in prolactin signal transduction in mammary epithelial cells. Oncogene 1996; 13: 1139-45.
45. Schwertfeger KL, Hunter S, Heasley LE et al. Prolactin stimulates activation of c-jun N-terminal kinase (JNK). Mol Endocrinol 2000; 14: 1592-602.
46. Erwin RA, Kirken RA, Malabarba MG, Farrar WL, Rui H. Prolactin activates Ras via signaling proteins SHC, growth factor receptor bound 2, and son of sevenless. Endocrinology 1995; 136: 3512-18.
47. Clevenger CV, Torigoe T, Reed JC. Prolactin induces rapid phosphorylation and activation of prolactin receptor-associated RAF-1 kinase in a T-cell line. J Biol Chem 1994; 269: 5559-65.
48. Clevenger CV, Ngo W, Sokol DL, Luger SM, Gewirtz AM. Vav is necessary for prolactin-stimulated proliferation and is translocated into the nucleus of a T-cell line. J Biol Chem 1995; 270: 13246-53.
49. Galandrini R, Palmieri G, Piccoli M, Frati L, Santoni A. Role for the Racl exchange factor Vav in the signaling pathways leading to NK cell cytotoxicity. J Immunol 1999; 162: 3148-52.
50. Lewis TS, Shapiro PS, Ahn NG. Signal transduction through MAP kinase cascades. Adv Cancer Res 1998; 74: 49-139.
51. fyn is associated with prolactin (PRL) receptor and is activated by PRL stimulation of T-lymphocytes. Mol Endocrinol 1994; 8: 674-81.
52. Han J, Das B, Wei W et al. Lck regulates Vav activation of members of the Rho family of GTPases. Mol Cell Biol 1997; 17: 1346-53.
53. Yu TX, Rillema JA. The MEK inhibitor PD 098059 inhibits prolactin-induced Nb2 cell mitogenesis but not milk product synthesis in cultured mouse mammary tissues. Biochim Biophys Acta 1998; 1448: 126-34.
54. Cheng Y, Zhizhin I, Perlman RL, Mangoura D. Prolactin-induced cell proliferation in PC12 cells depends on JNK but not ERK activation. J Biol Chem 2000; 275: 23326-32.
55. Whitmarsh AJ, Davis RJ. Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathways. J Mol Med 1996; 74: 589-607.
56. Schulze-Osthoff K, Ferrari D, Riehemann K, Wesselborg S. Regulation of NF-kappa B activation by MAP kinase cascades. Immunobiology 1997; 198:35-49.
57. Deng X, Xiao L, Lang W, Gao F, Ruvolo P, May WS Jr. Novel role for JNK as a stress-activated Bcl2 kinase. J Biol Chem 2001; 276: 23681-8.
58. Brazil DP, Hemmings BA. Ten years of protein kinase B signalling: A hard Akt to follow. Trends Biochem Sci 2001; 26: 657-64.
59. Al-Sakkaf KA, Mooney LM, Dobson PR, Brown BL. Possible role for protein kinase B in the antiapoptotic effect of prolactin in rat Nb2 lymphoma cells. J Endocrinol 2000; 167: 85-92.
60. Llovera M, Pichard C, Bernichtein S et al. Human prolactin (hPRL) antagonists inhibit hPRL-activated signaling pathways involved in breast cancer cell proliferation. Oncogene 2000; 19: 4695-705.
61. Cowley S, Paterson H, Kemp P, Marshall CJ. Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells. Cell 1994; 77: 841-52.
62. Sale EM, Atkinson PG, Sale GJ. Requirement of MAP kinase for differentiation of fibroblasts to adipocytes, for insulin activation of p90 S6 kinase and for insulin or serum stimulation of DNA synthesis. Eur Mol Biol J 1995; 14: 674-84.
63. Pircher TJ, Petersen H, Gustafsson JA, Haldosen LA. Extracellular signal-regulated kinase (ERK) interacts with signal transducer and activator of transcription (STAT) 5a. Mol Endocrinol 1999; 13: 555-65.
64. King A. Uterine leukocytes and decidualization. Human Reprod Update 2000; 6: 28-36.
65. Tessier C, Prigent-Tessier A, Ferguson-Gottschall S, Gu Y, Gibori G. PRL antiapoptotic effect in the rat decidua involves the PI3K/protein kinase B-mediated inhibition of caspase-3 activity. Endocrinology 2001; 142: 4086-94.
66. Dahmoun M, Boman K, Cajander S, Westin P, Backstrom T. Apoptosis, proliferation, and sex hormone receptors in superficial parts of human endometrium at the end of the secretory phase. J Clin Endocrinol Metabol 1999; 84: 1737-43.
67. Loke YW, King A. Immunology of human implantation: An evolutionary perspective. Human Reprod 1996; 11: 283-6.
68. Poropatich C, Rojas M, Silverberg SG. Polymorphonuclear leukocytes in the endometrium during the normal menstrual cycle. Int J Gynecol Pathol 1987; 6: 230-4.
69. ++ population. Dev Immunol 1991; 1: 169-90.
70. Loke YW, King A. Immunological aspects of human implantation. J Reprod Fertil Suppl 2000; 55: 83-90.
71. Li XF, Charnock-Jones DS, Zhang E et al. Angiogenic growth factor messenger ribonucleic acids in uterine natural killer cells. J Clin Endocrinol Metabol 2001; 86: 1823-34.
72. Smith SK. Angiogenesis, vascular endothelial growth factor and the endometrium. Human Reprod Update 1998; 4: 509-19.
73. Maisonpierre PC, Suri C, Jones PF et al. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 1997; 277: 55-60.
74. ++ large granular lymphocytes is amplified by decidual macrophages. Human Reprod 1997; 12: 921-4.
75. Tabibzadeh S. Regulatory roles of IFN-gamma in human endometrium. Ann N Y Acad Sci 1994; 734: 1-6.
76. Yeaman GR, Guyre PM, Fanger MW et al. Unique CD8+ T cell-rich lymphoid aggregates in human uterine endometrium. J Leukoc Biol 1997; 61: 427-35.
77. Nasu K, Matsui N, Narahara H, Tanaka Y, Miyakawa I. Effects of interferon-gamma on cytokine production by endometrial stromal cells. Human Reprod 1998; 13: 2598-601.
78. Arici A, Seli E, Zeyneloglu HB, Senturk LM, Oral E, Olive DL. Interleukin-8 induces proliferation of endometrial stromal cells: A potential autocrine growth factor. J Clin Endocrinol Metabol 1998; 83: 1201-5.
79. Strieter RM, Kunkel SL, Elner VM et al. Interleukin-8. A corneal factor that induces neovascularization. Am J Pathol 1992; 141: 1279-84.
80. Ashkar AA, Di Santo JP, Croy BA. Interferon gamma contributes to initiation of uterine vascular modification, decidual integrity, and uterine natural killer cell maturation during normal murine pregnancy. J Exp Med 2000; 192: 259-70.
81. Pellegrini I, Lebrun JJ, Ali S, Kelly PA. Expression of prolactin and its receptor in human lymphoid cells. Mol Endocrinol 1992; 6: 1023-31.
82. Dardenne M, Leite de Moraes MC, Kelly PA, Gagnerault MC. Prolactin receptor expression in human hematopoietic tissues analysed by flow cytofluorometry. Endocrinology 1994; 134: 2108-14.
83. Clevenger CV, Freier DO, Kline JB. Prolactin receptor signal transduction in cells of the immune system. J Endocrinol 1998; 157: 187-97.
84. Yu-Lee L-Y. Prolactin stimulates transcription of growth-related genes in Nb2 T lymphoma cells. Mol Cell Endocrinol 1990; 68: 21-8.
85. King A, Birkby C, Loke YW. Early human decidual cells exhibit NK activity against the K562 cell line but not against first trimester trophoblast. Cell Immunol 1989; 118: 337-44.
86. King A, Gardner L, Loke YW. Evaluation of oestrogen and progesterone receptor expression in uterine mucosal lymphocytes. Human Reprod 1996; 11: 1079-82.
87. Ohteki T, Yoshida H, Matsuyama T, Duncan GS, Mak TW, Ohashi PS. The transcription factor interferon regulatory factor 1 (IRF-1) is important during the maturation of natural killer 1.1+ T cell receptor-alpha/beta+ (NK1+ T) cells, natural killer cells, and intestinal intraepithelial T cells. J Exp Med 1998; 187: 967-72.